ManuPharma 2016
Date: 30 November - 01 December, 2016
Venue: The Westin Grand Frankfurt
Europe's first peer-led pharma event for Heads of Tech Ops, Heads of Manufacturing Ops and Site Leads
ManuPharma 2016 provides you with a “how to” guide to transform your manufacturing strategy to best meet changing product portfolio, regulatory and customer requirements.
Join us for this year’s best opportunity to benchmark on how other companies are embracing industry disruption and achieving success with disruptive technologies (industry 4.0, IoT, additive manufacturing), data integrity, MES, QbD, PAT, sterile manufacturing fill + finish and Continuous Manufacturing.
We understand your challenges, and have designed the agenda to help you to find out how to implement advanced manufacturing technology and benchmark your sites and systems. Through exchanging ideas with senior-level peers in our interactive round-tables and workshops you will be able to discuss your personal manufacturing challenges.
ManuPharma really is the most senior-level, bespoke event for the pharmaceutical manufacturing industry - whether you are at VP or Director level, if you specialise in manufacturing ops, tech ops, or leading a site.
Download the agenda: http://wbresear.ch/mppteueva Use our exclusive code when booking to save 15% - MANUTECH15 - http://wbresear.ch/mppteuevp
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
